Wound Healing
=============

Skin is the outer anatomical guard protecting us against the external environment. Skin is formed of 3 layers: epidermis, dermis and subcutaneous layer. Following skin injury, the synergetic interaction between different dermal cells in a process regulated at different levels is essential ([@B94]). The process of wound healing generally consists of four sequential but overlapping phases: (i) Hemostasis phase in which, platelets and coagulation factors lead to clotting and reduce blood loss ([@B55]); (ii) Inflammation phase is characterized by infiltration of various inflammatory cells to the wound site to eliminate the pathogens and secrete cytokines and growth factors ([@B25]; [@B55]); (iii) Proliferation phase is the rebuilding of extracellular matrix (ECM) at the wound site which involves angiogenesis, granulation tissue formation, collagen fibers deposition, epithelialisation and wound retraction ([@B146]); (iv) Remodeling phase is the maturation of scar tissue where type III collagen is replaced with type I collagen ([@B37]).

Proliferation Phase of Wound Healing
====================================

Proliferation phase lasts from 3 days up to 2 weeks following skin injury. Collectively, the proliferative phase is achieved through three main steps: re-epithelialization, angiogenesis and the formation of granulation tissue.

Re-epithelialization
--------------------

In re-epithelialization, keratinocytes at the wound edges proliferate actively and migrate to re-establish coverage of the wound site ([@B15]). In addition, stem cells from hair follicles or sweat glands in the vicinity of the wound also contribute to re-epithelialization ([@B84]; [@B95]; [@B64]). Keratinocytes disengage the desmosome/hemidesmosome junctions and reorganize their cytoskeleton in order to migrate over the wound site ([@B15]). Keratinocytes revert back to the normal phenotype after seizing migration and attach firmly to the re-established basement membrane and underlying dermis ([@B15]).

Angiogenesis
------------

Angiogenesis is a complex process of growth of new vessels from pre-existing blood vessels. This process is initiated in the early healing process when the hemostatic plug has formed and as platelets release transforming growth factor (TGF)-β, platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) ([@B40]). Together with hypoxia-inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF) which are released in response to hypoxia, these transcription factors and growth factors induce expression of several angiogenic genes, neovascularization and the repair of damaged blood vessels at the wound site ([@B146]; [@B40]). As angiogenesis proceeds, a rich vascular bed in the wound site that has many fold more capillaries than does normal tissue ([@B24]).

Granulation Tissue Formation
----------------------------

After skin wounding, proliferation and migration of fibroblasts to the wound site are induced by growth factors released from the platelets ([@B146]). In addition, fibroblasts also derived from bone-marrow-derived mesenchymal stem cell ([@B98]). Fibroblasts secrete a loose matrix of ECM proteins (i.e., glycosaminoglycans, proteoglycans and hyaluronic acid), fibronectin and collagen ([@B109]; [@B146]). The resulting vascularized fibrous tissue replacing the hemostatic clot at the wound site is known as granulation tissue.

Following the formation of granulation tissue, fibroblasts change to α-smooth muscle actin-expressing myofibroblast phenotype, which is triggered by mechanical tension, focal adhesion protein Hic-5 and activated TGF-β ([@B42]; [@B121]). Myofibroblast plays a major role in wound contraction, which begins approximately 7 days following injury, occurring at a rate of 0.75 mm/day ([@B146]). The final outcome will fill the wound gap with granulation tissue covered by surface epithelium, and the wound is ready for the last phase (remodeling).

MicroRNA
========

MicroRNA (miRNA) is a small non-coding RNA molecule which consists of about 18--25 nucleotides in length ([@B89]). The non-coding RNAs are RNA which do not code for proteins. However, some of them, including the ribosomal RNA, transfer RNA, small nuclear RNAs and small nucleolar RNAs, were reported to control various cell functions such as mRNA translation and regulation of gene expression ([@B81]) The non-coding RNA can be divided into short and long non-coding RNA depending on the number of nucleotides. Long non-coding RNAs are similar to mRNA and they range from 200 nucleotides to 100 kilobases in length. They are expressed in specific tissues to perform certain functions. Long non-coding RNAs include the antisense such as Oct4-pg5 and the brain-associated BC200 ([@B32]). On the other hand, many researchers discovered different small non-coding regulatory RNAs (18--100 nucleotides in length) in both animals and plants which mainly include snoRNAs and miRNAs ([@B81]). miRNA as one of the small non-coding RNAs was discovered first in the early 1990s by Victor Ambros through studies with the lin-4 gene in the nematode *Caenorhabditis elegans*. In cells, miRNA plays a major role in the regulation of gene expression and controlling various processes such as metabolism, cell proliferation, differentiation and apoptosis ([@B34]). miRNA regulate gene expression through binding to the 3′ untranslated region (UTR) of mRNA. This binding leads to mRNA degradation which in turn leads to inhibition of protein translation ([@B88]). Junk DNA was transcribed giving rise to different classes of non-coding RNA, including miRNAs, as a major part of human DNA which was thought to be with no function. Nowadays scientists have realized that a major part of the junk DNA is highly related to coding of miRNAs.

miRNAs are synthesized from primary miRNAs (pri-miRNAs) in two stages by the action of two RNase III-type proteins: Drosha in the nucleus and Dicer in the cytoplasm ([@B57]). Genes for miRNAs are transcribed to primary miRNA (pri-miRNA), which is then processed within the nucleus to precursor miRNA (pre-miRNA) by a class 2 RNase III enzyme (Drosha). Next, the pre-miRNAs are transported from the nucleus to the cytoplasm where they are processed to become mature miRNAs by an RNase III-type protein (Dicer). miRNAs are attached to the Argonaute protein to produce the RNA-induced silencing complex (RISC) ([@B123]). Several mechanisms were reported to regulate the biogenesis and expression of miRNAs ([@B56]). Those mechanisms include the single nucleotide polymorphisms (SNPs), which are induced by alternations in the nucleotides sequences of genes coding for miRNA. SNPs control the biogenesis and functions of miRNA by changing the coding sequences of variant miRNAs ([@B85]). Moreover, RNA editing, one of the major pathways of RNA modification at the post-transcriptional level, can lead to different miRNA expression. For instance, almost 16% of pri-miRNAs synthesize is induced by A-to-I nucleotide editing ([@B53]). Some miRNA genes are affected by hypermethylation thus; nearly 10% miRNAs expression is regulated by DNA methylation. Meanwhile, inhibition of methylation resulted in a decreased in expression of certain miRNA ([@B38]). The function of miRNAs is mainly related to the regulation of gene expression. A miRNA is complementary to a part of one or more mRNAs. Base pairing of RISC with the target RNA leads to inhibition of protein translation and/or mRNA degradation. miRNAs mainly bind their mRNA targets via a sequence between the 2nd and 8th nucleotides of their 5′ proximal region ([@B54]). It is noteworthy to mention that miRNA interferes with the target gene expression through repression of mRNA translation or degradation of mRNA achieved by deadenylation from 3′ end and/or decapping from 5′ end. A previous study reported that 48% miRNA target genes are principally regulated by translation repression, 29% are controlled by mRNA degradation, and 23% are regulated by both mechanisms ([@B51]). Moreover, in certain miRNA, the expression is promptly increased to millions of copies per cell aiming to degrade its target genes ([@B33]). In addition to the ability of miRNA to downregulate their target genes, they are also capable of upregulating the expression of genes. miRNA complex promotes the expression of target mRNAs similar to miRNA-mediated downregulation. The mRNA expression may be stimulated either by the direct effect of miRNA or indirectly through miRNA-mediated repression of other inhibitory miRNAs targeting the same gene ([@B120]). miRNA biogenesis and mechanism of action are shown in **Figure [1](#F1){ref-type="fig"}**.

![miRNA biogenesis and mechanisms of action (RISC, RNA-induced silencing complex; Pri-miRNA, Primary miRNA; Pre-miRNA, precursor miRNA).](fgene-09-00038-g001){#F1}

miRNA and Chronic Wound Healing
===============================

Chronic wounds such as leg ulcers, pressure ulcers, and diabetic foot ulcers (DFU) are common. Millions of people worldwide suffer from chronic wounds and their complications and thus are considered a major public health problem. In Germany, an epidemiology study revealed that there were 786,407 prevalent and 196,602 incident chronic wounds in the year of 2012 ([@B41]). Nearly 3 million US citizens are suffering from pressure ulcer, while much more are suffering from venous ulcers ([@B108]). It was also estimated that 15% of diabetic patients will suffer from diabetic ulcers, which is considered as a major source of morbidity and the main cause of hospitalization in diabetic patients ([@B1]; [@B67]; [@B106]). Treating these chronic wounds is estimated to cost about \$5--10 billion each year in the United States ([@B62]). In Singapore, the annual direct cost of chronic wound management in a tertiary hospital was about SGD 4.59 million while the total indirect costs (i.e., income loss due to hospitalization stay amounted to SGD 0.86 million ([@B116]).

Several studies have investigated the role of miRNA in skin metabolism. The following miRNAs were found to be heavily expressed in the skin: miR-152, miR-143, miR-126, miR-21, miR-27a, miR-214, miR-16, miR-203, miR-125b, miR-34a, miR-205, miR-27b, miR-30b, miR-125a, miR-191 and miR-200 family ([@B143]). Numerous studies have investigated the expression levels of various miRNAs in different phases of wound healing; suggesting miRNAs have a potential role in wound healing. In this review, we focus on the role of miRNA in the 3 main processes in the proliferation phase of wound healing: re-epithelialization, angiogenesis, and granulation tissue formation.

Role of miRNA in Re-epithelialization
-------------------------------------

The re-epithelialization process is considered a crucial step in wound healing ([@B105]). Collectively, it involves migration of keratinocytes to cover the newly formed granulation tissue. Several studies have investigated the role of miRNA in regulating the re-epithelialization process (**Table [1](#T1){ref-type="table"}**).

###### 

miRNAs involved in the re-epithelialization process in wound healing.

  miRNA     Effect                                                   Target            Reference
  --------- -------------------------------------------------------- ----------------- -----------------
  miR-21    Enhances keratinocyte migration.                         TIMP3, TIAM1      [@B142]
  miR-31    Promotes keratinocyte proliferation and migration.       EMP-1             [@B69]
  miR-203   Inhibits keratinocyte proliferation and migration.       RAN, RAPH1, P63   [@B122]; [@B20]
  miR-204   Inhibits epithelial cells proliferation and migration.   SMAD4, SIRT1      [@B132]; [@B5]
  miR-205   Enhances epithelial cells proliferation and migration.   SHIP2             [@B147]
  miR-210   Inhibits proliferation of epithelial cells.              E2F3              [@B31]; [@B9]

### miR-21

miR-21 has been reported that miRNA plays a crucial role in cell proliferation, EMT and migration through silencing its target genes ([@B28]; [@B60]). miR-21 promotes migration of cancer cells by targeting Reversion Inducing Cysteine-Rich Protein with Kazal motifs (RECK), TIMP metallopeptidase inhibitor 3 (TIMP3), and T-Cell Lymphoma Invasion And Metastasis 1 (TIAM1) genes ([@B28]; [@B19]). Recent studies demonstrated that miR-21 was highly expressed in the epidermis and hair follicle ([@B143]). Over-expression of miR-21 enhanced keratinocyte migration while miR-21 knockdown led to a remarkable delay in the re-epithelialization process ([@B142]). This may suggest that miR-21 is crucial for keratinocyte migration and re-epithelialization. TIMP3 and TIAM1 were identified as the direct target genes of miR-21 indicating that these genes are related to keratinocyte migration ([@B142]).

### miR-31

miR-31 was reported to have a role in cell differentiation and hair growth ([@B80]; [@B90]). Furthermore, the up-regulation of miR-31 has been reported in several skin conditions characterized by excessive keratinocyte proliferation such as psoriasis ([@B86]; [@B138]) and squamous cell carcinoma ([@B12]; [@B124]). The expression of miR-31 was gradually up-regulated in keratinocytes of wound edges in both inflammation and proliferative phases of wound healing. miR-31 promoted keratinocytes proliferation and migration by blocking epithelial membrane protein 1 ([@B69]). Moreover, miR-31 expression was stimulated by Transforming Growth Factor Beta 2 (TGF-β2), which was significantly expressed in the wound area ([@B69]).

### miR-203

miR-203 is considered the most abundant keratinocyte-related miRNA in the epidermis ([@B112]). Down-regulation of miRNA-203 promotes epithelial-mesenchymal transition (EMT) in various cancers ([@B135]; [@B97]). miR-203 possesses an anti-proliferative activity through targeting the mRNA of the transcription factor p63 ([@B66]; [@B144]). P63 was proven to have a role in keratinocyte proliferation in the normal and diseased skin ([@B103]; [@B65]). Two new targets of miR-203, Ras-related nuclear protein (RAN) and Ras Association and Pleckstrin Homology Domains 1 (RAPH1) are also found to be essential for the re-epithelialization process ([@B122]). miR-203 may control the expression of target proteins that are responsible for keratinocytes proliferation and migration. miR-203 was proven along with miR-210 to be key regulators of keratinocyte proliferation and migration ([@B20]). Following injury, miR-203 expression was down-regulated in highly proliferating keratinocytes. Injections of antagomiR-203 in the dorsal skin of newborn mice increased the expression of its target mRNAs: RAN and RAPH1 ([@B122]). Inhibitors of both miR-203 and miR-210 could represent a potential therapy to enhance the re-epithelialization process.

### miR-204

miR-204 is highly expressed in the epithelium of different eye tissues including the cornea, lens, and retina ([@B96]; [@B125]). It has been reported that miR-204 is crucial for the development of both lens and retinal ([@B17]). Moreover, miR-204 is essential for the homeostasis of retinal pigment epithelium ([@B125]). Although miR-204 is heavily detected in the cornea, its expression was down-regulation during corneal wound healing. Increased expression levels of miR-204 lead to inhibition of cell proliferation and migration ([@B5]). Therefore, down-regulation of miRNA-204 may enhance epithelial wound healing. A few target genes of miRNA-204 have been reported such as SMAD Family Member 4 (SMAD4) and Sirtuin 1 ([@B130]; [@B152]). Furthermore, SIRT1 is an essential gene target of miR-204 in both corneal cell culture and mice corneal wound healing ([@B5]). In a recent study, it was observed that SIRT1 enhanced proliferation and migration epithelial cells ([@B132]). This may support the fact that targeting of SIRT1 and SMAD4 by miR-204 leads to inhibition of proliferation and migration epithelial cells.

### miR-205

Keratinocyte-specific miR-205 is expressed abundantly in epithelial tissues, where it can be detected in the basal and superficial layers of stratified squamous epithelium ([@B96]; [@B143]). This indicates that miR-205 may be essential for development and homeostasis of epithelial cells ([@B35]). It has been reported that miR-205 suppressed SH2-containing phosphoinositide 5-phosphatase 2 (SHIP2) in human epidermal keratinocytes and corneal epithelial keratinocytes cell lines ([@B148]). SHIP2 is a lipid phosphatase enzyme that dephosphorylates phosphatidylinositol 3,4,5-triphosphate (PIP3), a critical second messenger in various pathways including Akt and phosphoinositide-dependent kinase-1 which is essential for keratinocytes migration ([@B3]; [@B13]). miR-205 plays a major role in keratinocyte migration thus, re-epithelialization process. miR-205 expression is down-regulated in migrating epithelial tongue during wound healing ([@B129]). This was proved by a study which used antagomiR-205 to reduce the expression levels of miR-205 in human epithelial cell lines. Treatment of human epithelial cell lines with antagomiR-205 increased SHIP2 levels and decreased the ability of the cells to close a scratch wounds ([@B147]). In addition, topical inhibition of miR-205 by administrating pluronic gel containing antagomiR-205 promotes keratinocyte migration in mouse wound model *in vivo* ([@B129]). Down-regulation of miR-205 resulted in an increased phosphorylation of the actin-severing protein cofilin, and a corresponding diminution of filamentous actin which suppressed the keratinocytes migration ([@B147]).

### miR-210

Over-expression of miR-210 is a consistent feature of the hypoxia response ([@B18]; [@B46]). Seven signature miRNAs (including miR-210) were found to be associated with low oxygen tension ([@B10]). HIF-1α is a transcription factor which regulates the hypoxic cycle of the cell has been found to arrest cell proliferation of keratinocytes ([@B101]). Recent studies observed that HIF-1α may also serve as a transcription factor for the expression of miRNAs ([@B102]). Another study observed that ischemic wounds possessed increased expression levels of the HIF-1α-dependent miR-210 ([@B9]). Furthermore, expression of E2F transcription factor 3 (E2F3) gene, a target gene of miR-210), which is essential for epithelial cells proliferation was significantly lower in ischemic wounds ([@B31]). These observations clarify that miR-210 may inhibit the proliferation of epithelial cells in chronic wounds.

Role of miRNA in Angiogenesis Process
-------------------------------------

Angiogenesis process is extremely vital for wound healing as it provides the essential oxygen and nutrients necessary for healing process ([@B70]). Chronic wounds are characterized by depressed angiogenesis which is mainly attributed to the impairment of migration of the endothelial cells through blood vessel wall to form vascular sprouts and reduced level of VEGF in diabetic wounds ([@B11]; [@B29]; [@B93]). miRNAs involved in angiogenesis are summarized in **Table [2](#T2){ref-type="table"}**.

###### 

miRNAs involved in the angiogenesis process of wound healing.

  miRNA        Effect                                                                        Target        Reference
  ------------ ----------------------------------------------------------------------------- ------------- -----------------
  miR-1        Inhibits tube formation and endothelial cells proliferation.                  VEGF-A        [@B137]
  miR-21       Inhibits of proliferation and migration of endothelial cells.                 PTEN, SMAD7   [@B50]; [@B49]
  miR-23a      Increases vascular permeability and cellular migration.                       PHD1, 2       [@B44]
  miR-29b      Inhibits neovascularization.                                                  VEGF, STAT3   [@B75],[@B76]
  miR-126      Enhances migration and repair of endothelial cells.                           SPRED1        [@B14]
  miR-133a/b   Stimulates proliferation and branch formation of endothelial cells.           TGF-β1        [@B114]
  miR-146a     Enhances new blood vessels formation.                                         VEGF, Pak1    [@B104]
  miR-210      Increases proliferation, migration and tube formation of endothelial cells.   Efna3         [@B45]; [@B127]
  miR-218      Inhibits neovascularization.                                                  ROBO1         [@B155]
  miR-377      Inhibits angiogenesis.                                                        CD133, VEGF   [@B68],[@B75]
  miR-939      Disrupts vascular integrity and inhibits angiogenesis.                        γ-catenin     [@B43]
  miR-4530     Promotes angiogenesis.                                                        VASH1         [@B154]

### miR-1

VEGF-A is considered the primary gene regulating angiogenesis process ([@B79]). In human cancers, VEGF-A levels are usually associated with bad prognosis and high mortality rate ([@B52]; [@B115]). miR-1 was found to suppress VEGF-A leading to inhibition of angiogenesis in tumor tissue ([@B113]). The expression of miR-1 was frequently down-regulated in tumor tissues compared to corresponding normal tissues. Meanwhile, up-regulation of miR-1 remarkably inhibited the tube formation and endothelial cells proliferation by suppressing the expression of VEGF-A ([@B137]).

### miR-21

miR-21 was reported to be over-expressed in multiple tumors in the last decade ([@B16]; [@B72]). Moreover, recent studies showed that miR-21 is considered as a potent anti-angiogenic factor through the inhibition of proliferation and migration of endothelial cells ([@B50]; [@B49]). miR-21 directly down-regulated the expression of both Phosphatase and Tensin Homolog (PTEN) and SMAD7 genes which are crucial in the regulation of angiogenesis process. Thus, over-expression of miR-21 inhibited endothelial cells proliferation, migration and tube formation ([@B127]).

### miR-23a

miR-23a is expressed in many cancers including breast cancer and colon cancer as a key regulator of cellular apoptosis and proliferation ([@B74]; [@B77]). A study showed that miR-23a was up-regulated in cells of lung cancer under hypoxic conditions leading to blocking its target prolyl hydroxylase 1 and 2 (PHD1 and 2) genes. Blocking of PHD1 and 2 led to the accumulation of HIF-1α in endothelial cells which in turn stimulated angiogenesis. Furthermore, miR-23a increased vascular permeability and cellular migration. On the other hand, down-regulation of miR-23a reduced angiogenesis process in cancer cells ([@B44]).

### miR-29b

miR-29b is a member of miR-29 family members which are known for their ability to induce transcriptional regulation, epigenetic modification and cell apoptosis ([@B39]; [@B87]). Expression of miR-29b is weak in malignant cells as they possess anti-tumor functions. miR-29b is currently identified as a fundamental regulator of EMT which is considered a common pathway of cancer metastasis and chemotherapy resistance ([@B140]). A recent study has investigated the role of miR-29b in angiogenesis of breast cancer. The results showed that miR-29b was down-regulated in tumor tissues ([@B75]). Moreover, miR-29b showed anti-angiogenesis and anti-tumorigenesis activities by suppressing vascularization of cancer tissue. It was suggested that miR-29b targeted Akt3 pathway and inhibited Akt3 mediated VEGF ([@B75]). These results may support the role miR-29b as an inhibitor of angiogenesis process. Another study reported that up-regulation of miR-29b suppressed the angiogenesis of cervical cancer cells *in vitro* and inhibited neovascularization *in vivo* through targeting Signal Transducer and Activator of Transcription 3 (STAT3) gene. On the other hand, down-regulation of miRNA-29b could enhance angiogenesis of cancer cells ([@B76]).

### miR-126

miR-126 plays a role in the vascular protection of endothelial cells ([@B149]). miR-126 can act as a tumor suppressor factor in the case of acute myeloid leukemia or act as an oncogene in case of colon cancer ([@B82]). miRNA-126 may support cancer progression through the promotion of angiogenesis process ([@B82]). It has been demonstrated that cigarette smoking released endothelial cells microparticles (EMPs) that contain miR-126. The increased miRNA-126-enriched EMPs promoted angiogenesis and endothelial homeostasis through enhancing migration and repair of endothelial cells ([@B14]). Sprouty Related EVH1 Domain Containing 1 (SPRED1) mRNA was identified as a gene target for miR-126. The miR-126 expression level in the peripheral blood of diabetic patients with DFU was lower than diabetic patients without DFU and the non-diabetic population ([@B150]). Following maggot debridement therapy, the miR-126 expression was increased in diabetic patients with DFU ([@B150]). The use of exosomes derived from miR-126-3p over-expressed synovial mesenchymal stem cells encapsulated in hydrogels in diabetic wound model successfully promote re-epithelialization and accelerate angiogenesis ([@B71]).

### miR-133a/b

In the human genome, there are three identified miRNA-133 species: miR-133a-1, miR-133a-2, and miR-133b found on chromosomes 18, 20 and 6 respectively ([@B48]). TGF-β1 gene is considered as one of the major targets of miR-133 ([@B107]). miR-133a and miR-133b expression were significantly decreased in lung tissue after hyperoxia. It was observed that transfection of lung cells with miR-133a/b mimics restored cell proliferation and branch formation of endothelial cells. Moreover, miR-133a/b mimics stimulated expression of angiogenic factors in endothelial cells ([@B114]). The previous observations suggest that decreased expression of miR-133 inhibits angiogenesis process.

### miR-146a

miR-146a is a well-identified miRNA which regulates inflammation and proliferation processes ([@B111]). It has been reported that miR-146a was up-regulated in osteoarthritis ([@B139]) and breast cancer ([@B63]). miR-146a targets P21 Activated Kinase 1 (PAK)1 gene, which in turn stimulated VEGF expression and formation of vascular branches. Moreover, miRNA-146a reduced fibrosis and enhanced new blood vessels formation ([@B104]). This suggests that miRNA-146 could regulate VEGF expression and promote angiogenesis process.

### miR-210

miR-210 has been reported to be commonly up-regulated in cells of the ischemic heart and cardiac tumors ([@B21]). Recent studies proved that over-expression of miR-210 stimulated angiogenesis and inhibited apoptosis of cardiac cells in case of myocardial infarction ([@B45]). Another study showed that miR-210 remarkably enhanced angiogenesis and cardiac function in ischemic heart disease ([@B127]). miR-210 was found to be up-regulated in mesenchymal stem cells which were used for treating myocardial infarction model. Moreover, miR-210 increased the proliferation, migration and tube formation of endothelial cells. Ephrin A3 (EFNA3) gene was identified as the target gene for miRNA-210 ([@B127]). The previously mentioned data elaborates the role of miR-210 as an angiogenic factor.

### miR-218

miR-218 is well-known to be expressed by motor neurons and its down-regulation can result in hyperexcitability and neurodegeneration due to its potential role in homeostasis of the nervous system ([@B4]). Furthermore, miR-218 was identified in cancer cells such as squamous cell carcinoma ([@B119]). miR-218 was found to have a potential anti-tumor function in bladder cancer ([@B118]) and nasopharyngeal carcinoma ([@B2]). A recent study reported that miR-218 inhibited neovascularization process *in vitro*. It was suggested that mechanism of action of miR-218 was mediated by targeting Roundabout Guidance Receptor 1 (ROBO1) gene ([@B155]). Based on previous results, we may consider miR-218 as an anti-angiogenic therapy in case of cancers. However, miR-218 inhibitor could promote angiogenesis process.

### miR-377

miR-377 is a crucial miRNA that plays a critical role in the pathogenesis of certain diseases such as diabetic nephropathy ([@B128]). miR-377 was down-regulated in specific cancers including ovarian cancer, prostatic cancer and lymphoma ([@B151]; [@B6]). Moreover, miR-377 was proven to inhibit proliferation and invasion of some human cancers such as glioblastoma ([@B153]). Both i*n vitro* and *in vivo* study showed that miR-377 over-expression inhibited the growth and angiogenesis of esophageal cancer while its down-regulation showed opposite effects ([@B68]).

### miR-939

miR-939 is a recently identified miRNA which was found to promote the cell proliferation in ovarian cancer ([@B145]). However, in breast cancer, miR-939 inhibited cell proliferation and metastasis ([@B22]). These findings may predict the variant roles of miRNA in different cancers. A recent study revealed that miRNA-939 was down-regulated in ischemic heart disease patients and it was found to disrupt vascular integrity and inhibit angiogenesis through targeting γ-catenin gene ([@B43]).

### miR-4530

miR-4530 expression was down-regulated in patients with diabetic retinopathy. Interestingly, miR-4530 possessed the ability to stimulate angiogenesis in endothelial cells ([@B23]). Vasohibin-1 (VASH1) gene was identified as one of the targets of miRNA-4530 ([@B154]). VASH1 gene is over-expressed in endothelial cells leading to inhibition of angiogenesis process as a negative feedback ([@B133]; [@B58]). Thus, by suppressing VASH1, miR-4530 may promote angiogenesis. miR-4530 was demonstrated to promote angiogenesis in breast cancer and to suppress breast cancer by inhibiting cell proliferation and induction of apoptosis ([@B154]).

Role of miRNA in Granulation Tissue Formation
---------------------------------------------

The formation of the granulation tissue is a significant step in wound healing as it regulates and organizes the growth of the wound tissue ([@B7]; [@B100]). In this phase, granulation tissue formed is composed of different molecules including glycosaminoglycans, proteoglycans, and hyaluronic acid. Numerous miRNAs have been reported to support the formation of granulation tissues (**Table [3](#T3){ref-type="table"}**).

###### 

miRNAs involved in granulation tissue formation in wound healing.

  miRNA        Effect                                                                               Target          Reference
  ------------ ------------------------------------------------------------------------------------ --------------- -----------
  miR-29       Inhibits collagen synthesis and angiogenesis.                                        HSP47           [@B36]
  miR-98       Decreases viability and increases apoptosis of fibroblasts.                          Col1α1          [@B8]
  miR-141-3p   Inhibits cell proliferation, migration of fibroblasts and enhances cell apoptosis.   --              [@B27]
  miR-185      Inhibits growth of fibroblasts.                                                      TGF-β1, Col-1   [@B136]

### miR-29

miR-29 was reported to have a significant role in the regulation of some biological processes including cell apoptosis ([@B59]) and proliferation ([@B134]). Various studies identified multiple target genes for miR-29 including genes coding for ECM component such as collagen and elastin genes ([@B61]; [@B131]). The miR-29b expression was significantly decreased during the healing process while the heat shock protein 47 (HSP47, a post-transcriptional target of miR-29b,) level was markedly increased, following full-thickness excisional wound and burn wound models ([@B156]). The local administration of miR-29b lentivirus inhibits HSP47 expression, collagen synthesis, and angiogenesis during skin wound healing ([@B156]). In addition, miR-29b reduces excessive scar formation by inhibition of TGF-β1/Smad/CTGF signaling pathway ([@B36]).

### miR-98

miR-98 has a role in the development of variant cancers. It inhibits tumor angiogenesis and invasion by decreasing the matrix metalloproteinase-11 enzyme levels ([@B110]). A recent study showed that miRNA-98 can regulate collagen, type I alpha 1 (Col1α1) gene expression in skin fibroblasts. Following transfection of fibroblasts with miR-98 mimic, there was a remarkable decline in Col1α1 gene expression leading to declining in the cell viability and increased apoptosis. On the other hand, transfection of cells with miR-98 inhibitor resulted in opposite effects ([@B8]). Fibroblast apoptosis is known as a key regulator in the development of normal and pathological scar ([@B99]). So that, miR-98 may play a role in wound healing by enhancing fibroblast proliferation and controlling scar formation.

### miR-141-3p

miR-141-3p was reported to suppress the growth and metastasis of prostatic tumor ([@B78]). Similarly, miR-141-3p inhibited invasion and metastasis of glioma ([@B91]). The over-expression of miR-141-3p inhibited cell proliferation and migration of skin fibroblasts as well as enhanced cell apoptosis, while its down-regulation resulted in the opposite effects ([@B27]).

### miR-185

miR-185 located on chromosome 22, was reported in various types of cancer including lung cancer ([@B73]), hepatoma ([@B92]), and stomach cancer ([@B117]). miR-185 has a role in wound healing and fibroblast migration ([@B141]). A recent study suggested that over-expression of miR-185 inhibited the growth of fibroblasts, through direct targeting of TGF-β1 and Col-1 genes, both serve a critical role in the development of hypertrophic scarring ([@B136]).

Therapeutic Strategies for Wound Healing and Future Directions
==============================================================

miRNA-based therapy will be a revolution in the advanced therapy for chronic wounds as they will be able to modulate a group of genes through the use of a single miRNA. The base upon which therapeutic miRNAs will be used relays on the ability to reduce the damaging miRNAs and up-regulate the levels of the beneficial miRNAs which could be achieved by several methods. Up-regulation of potentially beneficial miRNAs can be achieved by using synthetic double-stranded oligonucleotides called miRNA mimics. Mimics are double-stranded RNA which consists of the same sequence of the target miRNA in one strand which will be incorporated into the RISC complex ([@B26]). The down-regulation of potentially harmful miRNAs can be achieved by complementary oligonucleotides antagomiRs which act as competitive inhibitors through binding to the mature miRNA or lead to inhibition of miRNA maturation by binding to the pre-miRNA. Successful delivery of either mimics or antagomiRs depends mainly on their resistance to destruction in different tissues and binding affinity to the target miRNA. Therefore, chemical modifications of the oligonucleotides are required. Collectively, miRNA regulators can be delivered to mammalian tissues through either intravenous injection of oligonucleotides or conjugation of those oligonucleotides with other lipophilic molecules as high-density lipoproteins to facilitate their uptake by cells ([@B26]). Further studies investigating the role of different miRNAs in the phases of wound healing along with screening their target genes are recommended. A better understanding of the molecular mechanism of wound healing may provide better treatment and advanced solutions to chronic wounds. Various miRNA delivery systems were discovered in the last decade to convey miRNAs of choice into cells of wound tissue aiming to promote wound healing. Among those delivery systems, viral vectors are considered the most common and effective, despite few disadvantages including mutagenesis and restricted capacity for genetic material. Meanwhile, non-viral miRNA delivery systems, such as cationic polymers, peptides, and liposomes, are recognized by their lower toxicity, water solubility, and resistance to endonucleases or phagocytosis. These vectors are loaded with miRNAs and transfected into cutaneous cells to induce their function ([@B83]). Researchers conducted several experiments to deliver certain beneficial miRNAs into wound tissue. A previous study revealed significant effects of antihypoxamiR encapsulated lipid nanoparticles on ischemia during wound healing ([@B30]). Others reported that delivery of miR-27b mimics may improve wound healing through stimulating the bone marrow-derived angiogenic cell function in patients with type 2 diabetes mellitus ([@B126]). Systematic injection of anti-miR-26a improved angiogenesis process in mice through increasing SMAD1 gene expression ([@B47]).

Conclusion
==========

Numerous studies have demonstrated the important role of miRNA in wound healing, especially in chronic wounds. miRNAs are regulatory molecules that contribute to numerous aspects and phases of wound healing. They may play an important role to accelerate the wound healing process in chronic wounds.
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